Baird Initiates Coverage On Boston Scientific with Outperform Rating, Announces Price Target of $59
Portfolio Pulse from Benzinga Newsdesk
Baird analyst David Rescott has initiated coverage on Boston Scientific (NYSE:BSX) with an Outperform rating and a price target of $59.
July 19, 2023 | 9:37 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Boston Scientific has been given an Outperform rating by Baird with a price target of $59.
The Outperform rating from Baird indicates a positive outlook for Boston Scientific. The price target of $59 suggests that the analyst believes the stock has significant upside potential. This could lead to increased investor interest and potentially a rise in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100